|
| |
GABA-B-R1
| Symbol: | GABA-B-R1 | | Name(s): | metabotropic GABA-B receptor subtype 1 | | Type: | protein-coding | | Organism: | Drosophila melanogaster | | Synonyms: | BG:DS00929.6, CG15274, D-GABA[[B]]R1, D-Gaba1, GABA[[B]]R1, GB1, anon-WO0170980.175, anon-WO0170980.176 | | Links: |
Pubmed,
Entrez Gene,
Map Viewer.
|
Gene Information from Publications |
| Publication Link |
Summary of findings |
| 16054235 |
GABAB receptors are required for normal development and that the Drosophila model could be used to investigate the participating molecular mechanisms. |
Press Releases on GABA-B-R1:
|
 |
| Reportlinker Adds Ion Channel Modulator Pipelines: Targets and Agents in Development |
26th October, 2009 |
Reportlinker |
-- Prospects for ion channel modulators and commercial successes to date--
Pipeline activities, expert views, and survey results
Ion Channel Modulator Pipelines: Targets
|
| Henry Ford West Bloomfield Hospital Launches Gene Therapy Study for Parkinson's Disease |
6th October, 2009 |
Henry Ford Health System |
WEST BLOOMFIELD, Mich., Oct. 6 /PRNewswire/ -- Henry Ford West Bloomfield Hospital is embarking on a research study for advanced Parkinson's disease using a state-of-the-art
|
| Reportlinker Adds Therapeutics for Memory and Cognition Disorders Report |
3rd September, 2009 |
Reportlinker |
-- Analyzes the market outlook, trends, and challenges.
Chapter-1: SUMMARY
SUMMARY TABLE WORLDWIDE POTENTIAL MARKET FOR MEMORY/COGNITION
|
| Marinus Pharmaceuticals Adds Two Life Sciences Veterans to its Board of Directors |
29th July, 2009 |
Marinus Pharmaceuticals, Inc. |
BRANFORD, Conn., July 29 /PRNewswire/ -- Marinus Pharmaceuticals, Inc. a developer of drugs to treat serious neurological and psychiatric disorders, today announced the appointment of
|
| Jazz Pharmaceuticals and UCB Announce Second Phase III Study of Sodium Oxybate in Patients With Fibromyalgia Meets Primary Endpoints |
24th June, 2009 |
Jazz Pharmaceuticals, Inc. |
Preliminary top-line results of second Phase III study show highly significant decreases in pain and fatigue and improved daily function in fibromyalgia patients and confirm results from the
|
GABA-B-R1 results (if any) from reagent suppliers | 
|
Search Bioportfolio and other Life Science Sites for GABA-B-R1,
or search for GABA-B-R1 on BioPortfolio's antibody search engine.
This page has been viewed 94 times
Recent Search Terms used to find this page: .
Resources from the NCBI used on this page, NCBI's standard disclaimer applies.
|
